Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

DMAAU

Drugs Made In America Acquisition Corp.

CIK 0002028614 · Nasdaq

NasdaqFinancialsBlank Checks
$10.79
↑ 0.00 (0.00%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BearishOverall score · based on 2/4 lenses
FundamentalsOwnershipTechnicalsOptions

Risks: Fundamentals; Excluded: Ownership, Options (no data)

Key stats

Market Cap
$314.76M
P/E Ratio
51.64
EPS
Not covered
Dividend Yield
Not covered
52W Position
22%
Beta
0.09

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
-42.50
P/S
Not covered
EV/Revenue
Not covered
ROE
-82.3%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 22%
$10.30$12.50

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
$5.94M
Total Assets
$239.92M
Free Cash Flow
–

Recent news